Article
Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy
28 Mar 2019
Abstract excerpt
Background Platinum-based anticancer drugs are widely used in the chemotherapy of human neoplasms. The major obstacle for the clinical use of this class of drugs is the development of resistance and toxicity. It is therefore very important to understand the chemical properties, transport and metabolic pathways and mechanism of actions of these compounds. There is a large body of evidence that therapeutic and...
